Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas

NCT06870435 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

68649

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)
Screening
Epstein Barr Virus

Interventions

BIOLOGICAL: Blood, nasopharyngeal swab and saliva
DIAGNOSTIC_TEST: EBNA1-IgA, VCA-IgA, P85-Ab and EBV DNA
DIAGNOSTIC_TEST: Novel screening biomarkers
DIAGNOSTIC_TEST: Endoscopic examinations with or without biopsy

Sponsor

Ming-Yuan Chen